trending Market Intelligence /marketintelligence/en/news-insights/trending/aZUqa3InFDJQ9b8QaTeEyQ2 content esgSubNav
In This List

Biostar Pharmaceuticals director resigns

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Biostar Pharmaceuticals director resigns

Leung King Fai resigned as an independent director of Biostar Pharmaceuticals Inc., effective Dec. 12.

King Fai resigned because his director's fee from Jan. 1, 2014, to present had not been paid.